{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:38:07Z","timestamp":1787071087722,"version":"build-2736575974"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>This study aimed to determine the efficacy and safety of robotic-based fractionated stereotactic radiotherapy (FSRT) in the treatment of large brainstem metastases (BSMs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      Ten BSM were treated in ten patients with FSRT between January 2012 and December 2018. The median age was 61 years (range, 53\u201374 years) with a median Karnofsky Performance Score of 80 (range, 70\u201390). Four patients (40%) had received whole-brain radiotherapy prior to FSRT. The median tumor volume was 4.2 cm\n                      <jats:sup>3<\/jats:sup>\n                      (range, 1.35\u20138.18 cm\n                      <jats:sup>3<\/jats:sup>\n                      ) with a median prescription dose of 24 Gy (range, 16\u201324 Gy) delivered in 3\u20135 fractions (median three fractions) to the 56%\u201383% isodose line (median 70.5%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      <jats:sup>1<\/jats:sup>\n                      Median follow-up for the entire cohort was 14.1 months (range, 4.6\u201319.3 months). Five local recurrences were documented. Local control (LC) rate at 6 and 12 months was 90% and 64.2%, respectively. The median tumor volume of patients developing local recurrence was 5.42 cm\n                      <jats:sup>3<\/jats:sup>\n                      . Three patients experienced intracranial out-of-field failure for a 12-month intracranial control rate of 78.7%. Median overall survival and time to extracranial progression were 14.7 and 16.8 months, respectively. Toxicity was low with only one patient developing a new hemiparesis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Robotic-based FSRT for BSM appears to be safe with favorable LC and low toxicity even for large tumors.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_426_21","type":"journal-article","created":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T00:37:21Z","timestamp":1668645441000},"page":"1604-1609","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Fractionated stereotactic radiotherapy as a primary or salvage treatment for large brainstem metastasis"],"prefix":"10.4103","volume":"18","author":[{"given":"Georgios","family":"Chatzikonstantinou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Wolff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Tselis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-25-20241021","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1007\/s00415-002-0870-6","article-title":"Management of brain metastases","volume":"249","author":"Soffietti","year":"2002","journal-title":"J Neurol"},{"key":"R2-25-20241021","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1001\/archneur.1988.00520310047016","article-title":"Distribution of brain metastases","volume":"45","author":"Delattre","year":"1988","journal-title":"Arch Neurol"},{"key":"R3-25-20241021","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1200\/JCO.2005.04.6185","article-title":"Whole-brain radiotherapy in the management of brain metastasis","volume":"24","author":"Khuntia","year":"2006","journal-title":"J Clin Oncol"},{"key":"R4-25-20241021","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s13566-016-0281-4","article-title":"Radiosurgery for brainstem metastases with and without whole brain radiotherapy: Clinical series and literature review","volume":"6","author":"Murray","year":"2017","journal-title":"J Radiat Oncol"},{"key":"R5-25-20241021","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s11060-015-1927-6","article-title":"Brainstem metastases treated with stereotactic radiosurgery: Safety, efficacy, and dose response","volume":"125","author":"Trifiletti","year":"2015","journal-title":"J Neurooncol"},{"key":"R6-25-20241021","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ijrobp.2016.06.009","article-title":"Stereotactic radiosurgery for brainstem metastases: An international cooperative study to define response and toxicity","volume":"96","author":"Trifiletti","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R7-25-20241021","first-page":"40","article-title":"Gamma knife stereotactic radiosurgery in the treatment of brainstem metastases: The MD Anderson experience","volume":"2","author":"Voong","year":"2015","journal-title":"Neurooncol Pract"},{"key":"R8-25-20241021","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s11060-014-1373-x","article-title":"Local control and toxicity outcomes in brainstem metastases treated with single fraction radiosurgery: Is there a volume threshold for toxicity?","volume":"117","author":"Kilburn","year":"2014","journal-title":"J Neurooncol"},{"key":"R9-25-20241021","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3389\/fonc.2018.00379","article-title":"Hypofractionated radiation therapy for large brain metastases","volume":"8","author":"Masucci","year":"2018","journal-title":"Front Oncol"},{"key":"R10-25-20241021","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.ijrobp.2016.03.013","article-title":"Single-fraction versus multifraction (3\u00d79 Gy) stereotactic radiosurgery for large (>2 cm) brain metastases: A comparative analysis of local control and risk of radiation-induced brain necrosis","volume":"95","author":"Minniti","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R11-25-20241021","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s00066-018-1405-0","article-title":"Linac-based radiosurgery or fractionated stereotactic radiotherapy with flattening filter-free volumetric modulated arc therapy in elderly patients: A mono-institutional experience on 110 brain metastases","volume":"195","author":"Gregucci","year":"2019","journal-title":"Strahlenther Onkol"},{"key":"R12-25-20241021","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s00066-018-1262-x","article-title":"Improved effectiveness of stereotactic radiosurgery in large brain metastases by individualized isotoxic dose prescription: An in silico study","volume":"194","author":"Zindler","year":"2018","journal-title":"Strahlenther Onkol"},{"key":"R13-25-20241021","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/1748-717X-7-107","article-title":"Prescription dose and fractionation predict improved survival after stereotactic radiotherapy for brainstem metastases","volume":"7","author":"Leeman","year":"2012","journal-title":"Radiat Oncol"},{"key":"R14-25-20241021","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1093\/jrr\/rrx042","article-title":"Investigation of the efficacy and safety of CyberKnife hypofractionated stereotactic radiotherapy for brainstem metastases using a new evaluation criterion: 'Symptomatic control'","volume":"58","author":"Nakamura","year":"2017","journal-title":"J Radiat Res"},{"key":"R15-25-20241021","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1120\/jacmp.v17i3.6151","article-title":"Inverse treatment planning for spinal robotic radiosurgery: An international multi-institutional benchmark trial","volume":"17","author":"Blanck","year":"2016","journal-title":"J Appl Clin Med Phys"},{"key":"R16-25-20241021","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00066-018-1416-x","article-title":"ICRU report 91 on prescribing, recording, and reporting of stereotactic treatments with small photon beams: Statement from the DEGRO\/DGMP working group stereotactic radiotherapy and radiosurgery","volume":"195","author":"Wilke","year":"2019","journal-title":"Strahlenther Onkol"},{"key":"R17-25-20241021","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejca.2016.03.081","article-title":"RECIST 1.1-Update and clarification: From the RECIST Committee","volume":"62","author":"Schwartz","year":"2016","journal-title":"Eur J Cancer"},{"key":"R18-25-20241021","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ijrobp.2009.07.1750","article-title":"Stereotactic radiosurgery for single brainstem metastases: The Cleveland clinic experience","volume":"78","author":"Koyfman","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R19-25-20241021","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1227\/NEU.0b013e31821d31de","article-title":"Outcomes and prognostic factors for patients with brainstem metastases undergoing stereotactic radiosurgery","volume":"69","author":"Hatiboglu","year":"2011","journal-title":"Neurosurgery"},{"key":"R20-25-20241021","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2217\/cns-2017-0029","article-title":"Brainstem metastases treated with gamma knife stereotactic radiosurgery: The Indiana University Health experience","volume":"7","author":"Patel","year":"2018","journal-title":"CNS Oncol"},{"key":"R21-25-20241021","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3171\/jns.2006.105.2.213","article-title":"Gamma knife surgery for metastatic brainstem tumors","volume":"105","author":"Yen","year":"2006","journal-title":"J Neurosurg"},{"key":"R22-25-20241021","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s11060-007-9458-4","article-title":"Gamma knife radiosurgery for brainstem metastases: The UCSF experience","volume":"86","author":"Kased","year":"2008","journal-title":"J Neurooncol"},{"key":"R23-25-20241021","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ijrobp.2010.02.028","article-title":"Minimized doses for linear accelerator radiosurgery of brainstem metastasis","volume":"80","author":"Valery","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R24-25-20241021","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3171\/2012.7.GKS12977","article-title":"Gamma knife surgery for patients with brainstem metastases","volume":"117","author":"Kawabe","year":"2012","journal-title":"J Neurosurg"},{"key":"R25-25-20241021","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1227\/NEU.0b013e31823c40fe","article-title":"Accelerator-based stereotactic radiosurgery for brainstem metastases","volume":"70","author":"Lin","year":"2012","journal-title":"Neurosurgery"},{"key":"R26-25-20241021","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11060-013-1086-6","article-title":"Treatment of brainstem metastases with gamma-knife radiosurgery","volume":"113","author":"Seng\u00f6z","year":"2013","journal-title":"J Neurooncol"},{"key":"R27-25-20241021","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.clineuro.2016.05.001","article-title":"Utility of graded prognostic assessment in evaluation of patients with brainstem metastases treated with radiosurgery","volume":"147","author":"Joshi","year":"2016","journal-title":"Clin Neurol Neurosurg"},{"key":"R28-25-20241021","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jocn.2015.10.013","article-title":"CyberKnife radiosurgery for brainstem metastases: Management and outcomes and a review of the literature","volume":"25","author":"Liu","year":"2016","journal-title":"J Clin Neurosci"},{"key":"R29-25-20241021","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s11060-019-03195-y","article-title":"The case for radiosurgery for brainstem metastases","volume":"143","author":"Winograd","year":"2019","journal-title":"J Neurooncol"},{"key":"R30-25-20241021","doi-asserted-by":"crossref","first-page":"e348","DOI":"10.1016\/j.ijrobp.2018.07.1056","article-title":"Single fraction and fractionated radiosurgery for treatment of brainstem metastases","volume":"102","author":"Koffer","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_426_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:41:17Z","timestamp":1787067677000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_426_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_426_21","relation":{},"ISSN":["0973-1482"],"issn-type":[{"value":"0973-1482","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]}}}